# Selective Connexin43 Inhibition Prevents Isoproterenol-Induced Arrhythmias and Lethality in Muscular Dystrophy Mice

**Authors:** J. Patrick Gonzalez, Jayalakshmi Ramachandran, Lai-Hua Xie, Jorge E. Contreras, Diego Fraidenraich

PMC · DOI: 10.1038/srep13490 · 2015-08-27

## TL;DR

Inhibiting a specific heart protein prevents dangerous heart rhythms and death in mice with a severe muscle disease.

## Contribution

Selective inhibition of lateralized connexin43 prevents arrhythmias in muscular dystrophy mouse models.

## Key findings

- Cx43 is mislocalized and overexpressed in DMD mouse and human heart tissues.
- Inhibiting lateralized Cx43 prevents arrhythmias and death in mdx mice under stress.
- Selective Cx43 inhibition improves ECG outcomes in severe DMD mouse models.

## Abstract

Duchenne muscular dystrophy (DMD) is caused by an X-linked mutation that leads to the absence of dystrophin, resulting in life-threatening arrhythmogenesis and associated heart failure. We targeted the gap junction protein connexin43 (Cx43) responsible for maintaining cardiac conduction. In mild mdx and severe mdx:utr mouse models of DMD, and human DMD tissues, Cx43 was found to be pathologically mislocalized to lateral sides of cardiomyocytes. In addition, overall Cx43 protein levels were markedly increased in mouse and human DMD heart tissues examined. Electrocardiography on isoproterenol challenged mice showed that both models developed arrhythmias and died within 24 hours, while wild-type mice were free of pathology. Administering peptide mimetics to inhibit lateralized Cx43 function prior to challenge protected mdx mice from arrhythmogenesis and death, while mdx:utr mice displayed markedly improved ECG scores. These findings suggest that Cx43 lateralization contributes significantly to DMD arrhythmogenesis and that selective inhibition may provide substantial benefit.

## Linked entities

- **Genes:** GJA1 (gap junction protein alpha 1) [NCBI Gene 2697]
- **Proteins:** CONNEXIN 43 (CONNEXIN 43 protein), LYZ (lysozyme)
- **Chemicals:** isoproterenol (PubChem CID 3779)
- **Diseases:** Duchenne muscular dystrophy (MONDO:0010679), heart failure (MONDO:0005252)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Uts2r (urotensin 2 receptor) [NCBI Gene 217369] {aka Gpr14, UR-2-R, UTR, UTR2}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, Gja1 (gap junction protein, alpha 1) [NCBI Gene 14609] {aka Cnx43, Cx43, Cx43alpha1, Cxnk1, Gja-1, Npm1}, UTS2R (urotensin 2 receptor) [NCBI Gene 2837] {aka GPR14, UR-2-R, UTR, UTR2}, DMD (dystrophin) [NCBI Gene 1756] {aka BMD, CMD3B, DXS142, DXS164, DXS206, DXS230}, Scn5a (sodium channel, voltage-gated, type V, alpha) [NCBI Gene 20271] {aka Nav1.5, Nav1.5c, SkM1, SkM2, mH1}, Cdh2 (cadherin 2) [NCBI Gene 12558] {aka CDHN, N-CAD, Ncad}, Tat (tyrosine aminotransferase) [NCBI Gene 234724], Gja3 (gap junction protein, alpha 3) [NCBI Gene 14611] {aka Cnx46, Cx43, Cx46, Cxnj1, Gja-3}, Dmd (dystrophin, muscular dystrophy) [NCBI Gene 13405] {aka DXSmh7, DXSmh9, Dp427, Dp71, dys, mdx}, GJA1 (gap junction protein alpha 1) [NCBI Gene 2697] {aka AVSD3, CMDR, CX43, EKVP, EKVP3, GJAL}, Des (desmin) [NCBI Gene 13346], Utrn (utrophin) [NCBI Gene 22288] {aka DRP, Dmdl}, Panx1 (pannexin 1) [NCBI Gene 55991], PANX1 (pannexin 1) [NCBI Gene 24145] {aka MRS1, OOMD7, OZEMA7, PX1, UNQ2529}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}
- **Diseases:** DMD (MESH:D020388), hypertrophy (MESH:D006984), Muscular Dystrophy (MESH:D009136), loss of ambulation (MESH:D051346), DMD heart failure (MESH:D006333), pathology (MESH:D005598), respiratory failure (MESH:D012131), VT (MESH:D017180), bradycardia (MESH:D001919), inflammation (MESH:D007249), dilated cardiomyopathy (MESH:D002311), left ventricular dilation (MESH:C565277), Arrhythmia (MESH:D001145), pulmonary embolism (MESH:D011655), respiratory muscle degradation (MESH:D012133), muscle degeneration (MESH:D009410), overload (MESH:D019190), death (MESH:D003643), conduction related disorders (MESH:D019973), cardiac hypertrophy (MESH:D006332), muscle (MESH:D019042), AV block (MESH:D054537), tachycardia (MESH:D013610), arrhythmic (OMIM:212500), ischemia (MESH:D007511), infarct (MESH:D007238), cardiac fibrosis (MESH:D005355), cardiac disease (MESH:D006331), PVCs (MESH:D018879), cardiomyopathy (MESH:D009202),  (MESH:D004195),  (MESH:D009137)
- **Chemicals:** isopentane (MESH:C067038), glutathione (MESH:D005978), DAPI (MESH:C007293), calcium (MESH:D002118), Okadaic Acid (MESH:D019319), glycerol (MESH:D005990), NaF (MESH:D012969), Sodium Deoxycholate (MESH:D003840), HCl (MESH:D006851), sodium (MESH:D012964), PVDF (MESH:C024865), Nonidet P40 (MESH:C010615), SDS (MESH:D012967), EDTA (MESH:D004492), adrenaline (MESH:D004837), Gap 26 (-), steroid (MESH:D013256), nitrogen (MESH:D009584), Benzamidine (MESH:C032157), ATP (MESH:D000255), PBS (MESH:D007854), NaCl (MESH:D012965), 2,2,2-tribromoethanol (MESH:C062527), Iso (MESH:D007545),  (MESH:D010455)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** C57BL/10J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), C57BL/10ScSn — Homo sapiens (Human), Transformed cell line (CVCL_E097), DSHB — Mus musculus (Mouse), Hybridoma (CVCL_C2JJ)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4550874/full.md

---
Source: https://tomesphere.com/paper/PMC4550874